指南与共识姑息放疗与转移瘤放疗物理与技术

孤立性浆细胞瘤与多发性骨髓瘤的放射治疗:国际淋巴瘤放射肿瘤学组指南

Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
指南 / 共识 · Int J Radiat Oncol Biol Phys · 2018-06-20

国际淋巴瘤放射肿瘤学组通过文献综述与专家共识制定浆细胞肿瘤的检查与放疗管理指南,明确孤立性骨浆细胞瘤和髓外浆细胞瘤的根治性放疗靶区、剂量分割及随访,并讨论多发性骨髓瘤的姑息放疗作用。

要点

  • 浆细胞肿瘤约95%诊断为多发性骨髓瘤,局限性骨或髓外浆细胞瘤以根治性放疗为标准治疗。
  • 放疗使孤立性骨浆细胞瘤获得长期局部控制,对髓外浆细胞瘤可能治愈。
  • 指南基于国际辐射单位与测量委员会定义放疗体积,并提供具体病例的靶区与剂量分割建议。

核心结论

  • 国际淋巴瘤放射肿瘤学组提出孤立性浆细胞瘤根治性放疗应用与实施的标准化方法。
  • 同时讨论在新颖系统治疗时代姑息放疗对多发性骨髓瘤的支持作用。

研究设计与样本

  • 通过文献综述涵盖浆细胞肿瘤的分期、检查与放疗管理,由国际淋巴瘤放射肿瘤学组具有该病专长的国际放射肿瘤学家小组共识制定指南。
  • 放疗体积定义基于国际辐射单位与测量委员会。

主要发现

  • 浆细胞肿瘤约占美国成熟B细胞肿瘤的五分之一。
  • 约95%的浆细胞肿瘤诊断为多发性骨髓瘤,过去二十年新颖药物的系统治疗取得巨大进展,改善了疾病控制和生存。
  • 小部分患者表现为骨内局限性浆细胞瘤或髓外(骨外)软组织浆细胞瘤,根治性放疗是标准治疗。
  • 放疗为孤立性骨浆细胞瘤提供长期局部控制,对髓外病例可能治愈。

关键数值与推荐

  • 指南审查诊断检查、放疗原则与适应证、靶区定义、治疗计划及孤立性浆细胞瘤的随访流程。
  • 具体提供放疗体积和剂量/分割的详细建议,并以具体病例场景说明。
  • 讨论姑息放疗在多发性骨髓瘤中的作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop guidelines for the work-up and radiation therapy (RT) management of patients with plasma cell neoplasms. METHODS AND MATERIALS: A literature review was conducted covering staging, work-up, and RT management of plasma cell neoplasms. Guidelines were developed through consensus by an international panel of radiation oncologists with expertise in these diseases, from the International Lymphoma Radiation Oncology Group. RT volume definitions are based on the International Commission on Radiation Units and Measurements. RESULTS: Plasma cell neoplasms account for approximately one-fifth of mature B-cell neoplasms in the United States. The majority (∼95%) are diagnosed as multiple myeloma, in which there has been tremendous progress in systemic therapy approaches with novel drugs over the last 2 decades, resulting in improvements in disease control and survival. In contrast, a small proportion of patients with plasma cell neoplasms present with a localized plasmacytoma in the bone, or in extramedullary (extraosseous) soft tissues, and definitive RT is the standard treatment. RT provides long-term local control in the solitary bone plasmacytomas and is potentially curative in the extramedullary cases. This guideline reviews the diagnostic work-up, principles, and indications for RT, target volume definition, treatment planning, and follow-up procedures for solitary plasmacytoma. Specifically, detailed recommendations for RT volumes and dose/fractionation are provided, illustrated with specific case scenarios. The role of palliative RT in multiple myeloma is also discussed. CONCLUSIONS: The International Lymphoma Radiation Oncology Group presents a standardized approach to the use and implementation of definitive RT in solitary plasmacytomas. The modern principles outlining the supportive role of palliative RT in multiple myeloma in an era of novel systemic therapies are also discussed.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Tsang RW, Campbell BA, Goda JS, et al. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018. PMID: 29976492. doi:10.1016/j.ijrobp.2018.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。